Turnkey MLR solution enables 30-60% faster review cycles with compliance and scalability built in CHICAGO, IL, UNITED ...

As 2025 draws to a close, CDT editors are compiling a series of the most notable content (Chinese) from across the Chinese internet over the past year. Topics include this year’s most outstanding ...

Sunday's demonstration in Manhattan was peaceful, and it was not just against the shooting death of Good in Minneapolis, it ...

Floris D’Aalst’s essay “Whither America? Class and Politics in the Era of American Decline” covers a lot of ground. I appreciate that his overview of the unfolding crisis of us capitalism highlights ...

As Secretary of State, the President’s onetime foe now offers him lavish displays of public praise—and will execute his ...

Politicians talk a lot about tariffs, and much of what they say boils down to a simple question: Who pays? President Trump ...

Welcome to today’s session. [Operator Instructions] Please note that today’s call is being recorded. I would now like to turn ...

Monasterboice Any news If you have any Monasterboice related news, in the form of text or pictures, please don’t hesitate to ...

Q4 2025 Earnings Call January 15, 2026 11:00 AM ESTCompany ParticipantsJason ZandbergCody Slater - Chairman of the ...

U.S. Patent No. 12,329,781 relates to Minovia’s proprietary mitochondrial augmentation technology for the treatment of renal diseases, including renal tubulopathy, kidney insufficiency, and chronic ...

Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and ...